1,955 results on '"Waldmann, Thomas A."'
Search Results
2. A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies
3. Cell design and chemistry of commercial sodium-ion battery cells
4. EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma
5. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia
6. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma
7. Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies
8. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas
9. Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
10. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
11. NF-κB–induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia
12. Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma
13. Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia
14. The implications of IL-15 trans-presentation on the immune response
15. A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma
16. Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor
17. NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice
18. Trans -endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation
19. IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti–IL-2Rα therapies
20. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21
21. Immunometabolism at the nexus of cancer therapeutic efficacy and resistance
22. Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
23. First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
24. Temperature-driven path dependence in Li-ion battery cyclic aging
25. Observation of preferential sputtering of Si/graphite anodes from Li-ion cells by GD-OES and its validation by neutron depth profiling
26. Aging Mechanism For Calendar Aging of Li-Ion Cells With Si/Graphite Anodes
27. Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
28. Insights into Thermal Runaway of Cylindrical Lithium-ion Batteries by Internal Temperature Sensors.
29. Lithium Redistribution Mechanism within Silicon-Graphite Electrodes: Multi-Method Approach and Method Validation.
30. A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
31. IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
32. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma
33. Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells
34. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively
35. IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
36. Central Memory Self/Tumor-Reactive CD8 + T Cells Confer Superior Antitumor Immunity Compared with Effector Memory T Cells
37. Survival Adjustment of Mature Dendritic Cells by IL-15
38. Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
39. IL-15/IL-15Rα-Mediated Avidity Maturation of Memory CD8+ T Cells
40. IL-2 and IL-15 Receptor α-Subunits Are Coexpressed in a Supramolecular Receptor Cluster in Lipid Rafts of T Cells
41. Humanized Anti-CD25 (Daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β
42. IL-15 Enhances the in vivo Antitumor Activity of Tumor-Reactive CD8 + T Cells
43. Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations
44. 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
45. Multistep Improvement of Pilot-Scale 21700 Cells for Increased Fast-Charging Capability: Combining Optimized Electrolyte, Cell Design and Fast-Charging Protocol
46. Distinct Pathways Involving the FK506-Binding Proteins 12 and 12.6 Underlie IL-2- versus IL-15-Mediated Proliferation of T Cells
47. Coadministration of HIV Vaccine Vectors with Vaccinia Viruses Expressing IL-15 but Not IL-2 Induces Long-Lasting Cellular Immunity
48. Pretarget Radiotherapy with an Anti-CD25 Antibody-Streptavidin Fusion Protein Was Effective in Therapy of Leukemia/Lymphoma Xenografts
49. JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics
50. IL-15 Plays a Major Role in the Persistence of Tax-Specific CD8 Cells in HAM/TSP Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.